Rationale: A brief statement of purpose of the study and the hypothesis to be tested.
Methods: Summarize the predictors and outcomes analyzed, as well as the methods used. For abstracts reporting clinical research, a sentence or phrase presenting the most important selection criteria for subjects should be included.
Results: Provide a summary of the results including quantitative data, presented in sufficient detail with statistical analysis when possible to support the conclusions.
Conclusions: Summarize the impact and significance of the findings. It is not sufficient to state, “The results will be discussed,” or “other data will be presented,” etc.
Be sure to use the words “Rationale, Methods, Results and Conclusions” in the body of your abstract to indicate the start of each new section. See the Sample Abstract included in this document. Author information should not be included in the body of the abstract.
The disclosure statement submitted together with the abstract will be published online at the Meeting website, and you should include the statement on the first slide of your e poster.
The maximum length of an abstract for presentation at the 2018 Meeting is 250 words. Use of the words “Rationale, Methods, Results and Conclusions” as described above will not count towards the 250 word total.
Capitalize only the first letter of each word of the title.
Author Names and Affiliations
List authors followed by affiliations, separated by semi-colons. Superscript numbers should be used after each author’s name in cases where there are multiple affiliations.
The use of standard abbreviations is desirable (i.e., rbc, kg, mg). A special or unusual abbreviation should be placed in parentheses after the first appearance of the full word which it represents. Do not use periods after abbreviations or initials. Numerals rather than words should indicate numbers, except to begin sentences.
Non-proprietary (generic) names are preferred and should be used in the title of the abstract. Generic drug names are not capitalized in the body of the abstract. If a proprietary drug name is used in the body of the abstract, the first letter is capitalized.
You may use your word processor’s capabilities for bold, underline, italic, subscript and superscript, or use the tools provided when entering your abstract. Bold the words Rationale, Methods, Results and Conclusions used to separate one section of the abstract from another. Text that will be in italics in published form (e.g., genus, species) may be formatted as italics.
Abstracts will be graded by several reviewers on the following criteria; Clinical or basic science significance, Methodology and as an Overall submission. Reviewers are also asked to flag abstracts that involve research on human or animal subjects if the corresponding approvals are missing.